Koppula et al. have reported that CoQ-FSP1 is another downstream effector from the KEAP1-NRF2 axis, and the FSP1 inhibition has been associated with increased radiotherapy response of KEAP1 deficient lung cancer cells via inducing ferroptosis [113]. Here, KEAP1 is linked to lung carcinoma.